Donate

Safety Announcement Concerning TNF Blockers

Home»Science»Clinical Trials»Safety Announcement Concerning TNF Blockers
Safety Announcement Concerning TNF Blockers

Safety Announcement Concerning TNF Blockers, The is informing the public that it continues to receive reports of a of (known as or ), primarily in adolescents and young adults being treated for Crohn’s disease and with medicines known as (TNF) blockers, as well as with , and/or mercaptopurine.

Read the Safety Announcement Concerning TNF Blockers full storyFDA Safety Announcement Concerning TNF Blockers

You must be logged in to post a comment Login

No Guts Know Glory

IDEAS Kids

IDEAS Kids

IBD Adventures